Yukihiko Aramaki Selected Research

Yukihiko Aramaki Research Topics

Disease

14	Neoplasms (Cancer) 01/2014 - 04/2006
4	Inflammation (Inflammations) 01/2007 - 10/2005
3	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2015
3	Atopic Dermatitis (Atopic Eczema) 01/2007 - 10/2005
2	Muscular Dystrophies (Muscular Dystrophy) 03/2014 - 01/2012
2	Ischemia 01/2014 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2012 - 03/2003
1	Pneumococcal Infections 08/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2014
1	Carcinogenesis 01/2012
1	Mucositis 05/2011
1	Ovarian Neoplasms (Ovarian Cancer) 05/2011
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2011
1	Arthritis (Polyarthritis) 11/2010
1	Bacteremia 09/2009
1	Sepsis (Septicemia) 09/2009
1	Skin Diseases (Skin Disease) 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2006
1	Hepatoblastoma 03/2003

Drug/Important Bio-Agent (IBA)

16	Liposomes (Liposome)IBA 08/2018 - 03/2003
5	Peptides (Polypeptides)IBA 07/2013 - 02/2010
5	CPG-oligonucleotideIBA 03/2007 - 10/2005
4	VaccinesIBA 01/2021 - 01/2015
4	Syndecan-2IBA 05/2011 - 01/2010
3	AntigensIBA 08/2018 - 10/2005
3	LigandsIBA 05/2011 - 02/2010
3	CytokinesIBA 11/2010 - 10/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013 - 05/2011
2	Laminin (Merosin)IBA 05/2011 - 08/2010
2	SyndecansIBA 05/2011 - 02/2010
1	PolyphenolsIBA 01/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 08/2018
1	3- (N- (N',N'- dimethylaminoethane)carbamoyl)cholesterolIBA 08/2018
1	pneumococcal surface protein AIBA 08/2018
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Biocompatible Materials (Biomaterials)IBA 07/2013
1	Contrast MediaIBA 07/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2012
1	contrast agent BR1IBA 12/2012
1	SolutionsIBA 06/2012
1	IntegrinsIBA 05/2012
1	aspartyl- phenylalanyl- lysyl- leucyl- phenylalanyl- alanyl- valyl- tyrosyl- isoleucyl- lysyl- tyrosyl- arginineIBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Nucleic AcidsIBA 01/2012
1	ChemokinesIBA 01/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2010
1	laminin AIBA 02/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2009
1	Clodronic Acid (Clodronate)IBA 09/2009
1	Interleukin-1 (Interleukin 1)IBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2007
1	ProstaglandinsIBA 03/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2007
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2007
1	OligodeoxyribonucleotidesIBA 01/2007
1	Immunoglobulin E (IgE)IBA 01/2007
1	poly(ethylene glycol)-folateIBA 04/2006
1	stearylamineIBA 04/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2006
1	Immunoglobulin IsotypesIBA 10/2005
1	Cyclin AIBA 03/2003
1	Asialoglycoprotein ReceptorIBA 03/2003

Therapy/Procedure

9	Therapeutics 03/2014 - 03/2007
1	Microbubbles 12/2012
1	Immunotherapy 01/2007